Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading 4.9% Higher – Should You Buy?

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) traded up 4.9% during trading on Tuesday . The company traded as high as $16.60 and last traded at $16.60. 664 shares traded hands during trading, a decline of 97% from the average session volume of 19,786 shares. The stock had previously closed at $15.82.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research note on Tuesday, November 19th. UBS Group initiated coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They set a “buy” rating and a $21.00 price objective on the stock.

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.